speb/financial-data huggingface dataset:
Financial ratios for THNC.TO — quarterly report dated 2025-09-30
Total revenue: 13362589.928057555
Gross profit: 9746043.165467627
Operating income: -164748.20143884892
Net income: 122302.1582733813
Capital expenditures: 102158.27338129497
Operating cash flow: 452517.9856115108
Depreciation & amortization: 233093.52517985614
Net tangible assets: 30640287.769784175
Owner earnings: 253237.41007194243
Return on net tangible assets (%): 0.8264850903968066
Buffett classification: The Gruesome
Stock price: 1.4388489208633095
P/E ratio: 143.84915735960823
Shares outstanding: 67408713
Book value: 30776258.99280576
P/B ratio: 3.151486149746371
Market cap (USD): 96990953.95683454
Debt to equity: 0.03595221954697398
Current ratio: 3.2133217711777142
Quick ratio: 3.2133217711777142
COGS to revenue (%): 27.064714116506945
R&D to revenue (%): 29.837407128243782
SG&A to revenue (%): 44.33078496823517
Free cash flow (dilution-adjusted): -251798.5611510792
Buyback yield (%): 0.3790311202054844
Retained earnings: -53447482.014388494
Receivables turnover: 4.276767211604882
Capitalized R&D asset: 7731825.205304595
ROCI (R&D-adjusted, %): 0.12908157914324894
Rosenberg metric: 0.01385692792567326
FCF margin (%): -1.8843544739959084
Revenue growth (%): 1.153432431422545
Rule of 40 score: -0.7309220425733634
Financial ratios for THNC.TO — annual report dated 2025-12-31
Total revenue: 53421897.810218975
Gross profit: 39070072.992700726
Operating income: -967153.2846715328
Net income: 940875.912408759
Capital expenditures: 188321.16788321166
Operating cash flow: 4079562.04379562
Depreciation & amortization: 977372.2627737225
Net tangible assets: 31442335.766423356
Owner earnings: 1729927.0072992698
Return on net tangible assets (%): 5.501903612220261
Buffett classification: The Gruesome
Stock price: 1.4160583941605838
P/E ratio: 101.45298930954229
Shares outstanding: 67408713
Book value: 31574452.554744527
P/B ratio: 3.0231616436646087
Market cap (USD): 95454673.88321167
Debt to equity: 0.03393670388607623
Current ratio: 3.2419004131332896
Quick ratio: 3.2419004131332896
COGS to revenue (%): 26.86505984587637
R&D to revenue (%): 29.51440126796743
SG&A to revenue (%): 45.43094496365524
Free cash flow (dilution-adjusted): 1152554.7445255471
Buyback yield (%): 2.343757708616236
Retained earnings: -53975182.48175182
Receivables turnover: 12.37538045316199
Capitalized R&D asset: 29559959.228727475
ROCI (R&D-adjusted, %): 0.30188484017830786
Rosenberg metric: 0.29178457554528003
FCF margin (%): 2.157457506695086
Revenue growth (%): 14.118660734087921
Rule of 40 score: 16.276118240783006
Financial ratios for THNC.TO — quarterly report dated 2025-12-31
Total revenue: 13629197.08029197
Gross profit: 9875182.481751824
Operating income: -44525.54744525547
Net income: 252554.74452554743
Capital expenditures: 72262.77372262774
Operating cash flow: -359854.01459854015
Depreciation & amortization: 240145.98540145982
Net tangible assets: 31442335.766423356
Owner earnings: 420437.9562043795
Return on net tangible assets (%): 1.3371715108180888
Buffett classification: The Gruesome
Stock price: 1.4160583941605838
P/E ratio: 102.99278481586488
Shares outstanding: 67408713
Book value: 31574452.554744527
P/B ratio: 3.0231616436646087
Market cap (USD): 95454673.88321167
Debt to equity: 0.03393670388607623
Current ratio: 3.2419004131332896
Quick ratio: 3.2419004131332896
COGS to revenue (%): 27.543916023993148
R&D to revenue (%): 31.142887746358184
SG&A to revenue (%): 41.63988860325622
Free cash flow (dilution-adjusted): -994890.510948905
Buyback yield (%): 0.3486960897647647
Retained earnings: -53975182.48175182
Receivables turnover: 3.1572539736219145
Capitalized R&D asset: 8203571.916189676
ROCI (R&D-adjusted, %): 0.38278752406794997
Rosenberg metric: 0.032389687772470775
FCF margin (%): -7.299700085689803
Revenue growth (%): 1.9951757381599884
Rule of 40 score: -5.304524347529815
Financial ratios for TRNS — annual report dated 2022-03-31
Total revenue: 204959000
Gross profit: 58439000
Operating income: 14143000
Net income: 11380000
Capital expenditures: 10043000
Operating cash flow: 17618000
Depreciation & amortization: 9567000
Net tangible assets: 6410000
Owner earnings: 10904000
Return on net tangible assets (%): 170.10920436817474
Capex to operating income (%): 71.01039383440572
Buffett classification: The Good
Stock price: 81.14
P/E ratio: 66.59966921968366
Shares outstanding: 9340698
Book value: 86176000
P/B ratio: 8.79484120544003
Market cap (USD): 757904235.72
Debt to equity: 0.6689333457111029
Current ratio: 2.154601226993865
Quick ratio: 1.695849873691808
Effective tax rate (%): 13.722517058377559
Interest coverage ratio: 17.460493827160494
COGS to revenue (%): 71.48746822535239
SG&A to revenue (%): 21.61212730350948
Free cash flow (dilution-adjusted): 5137000
Buyback yield (%): 0.8817736707397115
Retained earnings: 58744000
Inventory turnover: 11.526117054751415
Receivables turnover: 5.0864623402407245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.425399194945753
FCF margin (%): 2.5063549295224896
Rule of 40 score: 2.5063549295224896
Financial ratios for TRNS — annual report dated 2023-03-31
Total revenue: 230569000
Gross profit: 68355000
Operating income: 16248000
Net income: 10688000
Capital expenditures: 9404000
Operating cash flow: 16951000
Depreciation & amortization: 10955000
Net tangible assets: 16471000
Owner earnings: 12239000
Return on net tangible assets (%): 74.30635662679862
Capex to operating income (%): 57.87789266371246
Buffett classification: The Good
Stock price: 89.39
P/E ratio: 78.1217247586078
Shares outstanding: 9340698
Book value: 99630000
P/B ratio: 8.380658378199337
Market cap (USD): 834964994.22
Debt to equity: 0.6464920204757603
Current ratio: 2.387138922240271
Quick ratio: 1.7893212797513949
Effective tax rate (%): 20.75331800993549
Interest coverage ratio: 6.722383119569715
COGS to revenue (%): 70.35377696047604
SG&A to revenue (%): 22.599308666819912
Free cash flow (dilution-adjusted): 4160000
Buyback yield (%): 0.05353517849183299
Retained earnings: 69163000
Inventory turnover: 9.582019020615512
Receivables turnover: 5.100632687372799
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.70429609809414
FCF margin (%): 1.804232138752391
Revenue growth (%): 12.495181963221913
Rule of 40 score: 14.299414101974305
Financial ratios for TRNS — annual report dated 2024-03-31
Total revenue: 259481000
Gross profit: 83806000
Operating income: 19781000
Net income: 13647000
Capital expenditures: 13280000
Operating cash flow: 32616000
Depreciation & amortization: 13544000
Net tangible assets: 99597000
Owner earnings: 13911000
Return on net tangible assets (%): 13.96728817133046
Capex to operating income (%): 67.13512966988525
Buffett classification: The Good
Stock price: 111.43
P/E ratio: 76.26833576170587
Shares outstanding: 9340698
Book value: 225169000
P/B ratio: 4.6224568130604125
Market cap (USD): 1040833978.1400001
Debt to equity: 0.09565703982342152
Current ratio: 3.1391384817457237
Quick ratio: 2.61918266216902
Effective tax rate (%): 25.988394164542544
Interest coverage ratio: 10.77983651226158
COGS to revenue (%): 67.70245220266608
SG&A to revenue (%): 24.674253606237066
Free cash flow (dilution-adjusted): 14824000
Buyback yield (%): 0.4713527904582017
Retained earnings: 80074000
Inventory turnover: 10.085830749799058
Receivables turnover: 5.373946360153257
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.786170602197179
FCF margin (%): 5.712942373430039
Revenue growth (%): 12.539413364329116
Rule of 40 score: 18.252355737759153
Financial ratios for TRNS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 120.77
Shares outstanding: 9340698
Market cap (USD): 1128076097.46
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRNS — quarterly report dated 2024-12-31
Total revenue: 66754000
Gross profit: 19679000
Operating income: 2100000
Net income: 2357000
Capital expenditures: 2869000
Operating cash flow: 12598000
Depreciation & amortization: 4428000
Net tangible assets: 46781000
Owner earnings: 3916000
Return on net tangible assets (%): 8.370919817874778
Capex to operating income (%): 136.61904761904762
Buffett classification: The Gruesome
Stock price: 105.74
P/E ratio: 104.76086195587611
Shares outstanding: 9340698
Book value: 281080000
P/B ratio: 3.513894288174185
Market cap (USD): 987685406.52
Debt to equity: 0.2348690764195247
Current ratio: 2.4167113860917326
Quick ratio: 1.981312541431232
Effective tax rate (%): 24.672419303291786
Interest coverage ratio: 10.552763819095478
COGS to revenue (%): 70.5201186445756
SG&A to revenue (%): 26.33400245678161
Free cash flow (dilution-adjusted): 9277000
Buyback yield (%): 0.01842692002924867
Retained earnings: 88106000
Inventory turnover: 3.412963097223229
Receivables turnover: 1.2750262630121287
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5926678520023707
FCF margin (%): 13.897294544147169
Rule of 40 score: 13.897294544147169
Financial ratios for TRNS — annual report dated 2025-03-31
Total revenue: 278421000
Gross profit: 89453000
Operating income: 17874000
Net income: 14515000
Capital expenditures: 13197000
Operating cash flow: 38985000
Depreciation & amortization: 18567000
Net tangible assets: 55175000
Owner earnings: 19885000
Return on net tangible assets (%): 36.03987313094699
Capex to operating income (%): 73.8335011748909
Buffett classification: The Good
Stock price: 74.45
P/E ratio: 47.91009067171891
Shares outstanding: 9340698
Book value: 286880000
P/B ratio: 2.4240622075432237
Market cap (USD): 695414966.1
Debt to equity: 0.201223508087005
Current ratio: 2.291888239269031
Quick ratio: 1.8663807033522344
Effective tax rate (%): 20.79559096365819
Interest coverage ratio: 22.398496240601503
COGS to revenue (%): 67.87131717794276
SG&A to revenue (%): 25.7089084515895
Free cash flow (dilution-adjusted): 22540000
Buyback yield (%): 0.5126435543935872
Retained earnings: 92524000
Inventory turnover: 13.047573016640198
Receivables turnover: 4.944081400717406
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.089335288506713
FCF margin (%): 8.095653704282364
Revenue growth (%): 7.299185682188676
Rule of 40 score: 15.394839386471041
Financial ratios for TRNS — quarterly report dated 2025-03-31
Total revenue: 77134000
Gross profit: 25913000
Operating income: 6940000
Net income: 4464000
Capital expenditures: 2695000
Operating cash flow: 10628000
Depreciation & amortization: 5626000
Net tangible assets: 55175000
Owner earnings: 7395000
Return on net tangible assets (%): 13.40280924331672
Capex to operating income (%): 38.8328530259366
Buffett classification: The Good
Stock price: 74.45
P/E ratio: 38.94573062836022
Shares outstanding: 9340698
Book value: 286880000
P/B ratio: 2.4240622075432237
Market cap (USD): 695414966.1
Debt to equity: 0.201223508087005
Current ratio: 2.291888239269031
Quick ratio: 1.8663807033522344
Effective tax rate (%): 28.644501278772378
Interest coverage ratio: 14.734607218683651
COGS to revenue (%): 66.40521689527316
SG&A to revenue (%): 24.597453781730493
Free cash flow (dilution-adjusted): 6760000
Buyback yield (%): 0.051336254956103965
Retained earnings: 92524000
Inventory turnover: 3.536629151418905
Receivables turnover: 1.3697126824590689
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.976053871670392
FCF margin (%): 8.763969196463298
Revenue growth (%): 15.549629984720017
Rule of 40 score: 24.313599181183314
Financial ratios for TRNS — quarterly report dated 2025-06-30
Total revenue: 76424000
Gross profit: 25821000
Operating income: 5338000
Net income: 3261000
Capital expenditures: 4598000
Operating cash flow: 3623000
Depreciation & amortization: 5605000
Net tangible assets: 63489000
Owner earnings: 4268000
Return on net tangible assets (%): 6.722424356975224
Capex to operating income (%): 86.13713001124016
Buffett classification: The Gruesome
Stock price: 85.96
P/E ratio: 79.63959532632413
Shares outstanding: 9340698
Book value: 292536000
P/B ratio: 2.74470971121503
Market cap (USD): 802926400.0799999
Debt to equity: 0.2246697842316843
Current ratio: 2.919868035190616
Quick ratio: 2.3556451612903224
Effective tax rate (%): 28.565169769989048
Interest coverage ratio: 11.835920177383592
COGS to revenue (%): 66.21349314351512
SG&A to revenue (%): 26.80179001360829
Free cash flow (dilution-adjusted): -2105000
Buyback yield (%): 0
Retained earnings: 95790000
Inventory turnover: 3.287616943866944
Receivables turnover: 1.3095495125002141
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4614407429309855
FCF margin (%): -2.754370354862347
Revenue growth (%): -0.9204760546581274
Rule of 40 score: -3.674846409520474
Financial ratios for TRNS — quarterly report dated 2025-09-30
Total revenue: 82272000
Gross profit: 26762000
Operating income: 3505000
Net income: 1269000
Capital expenditures: 4432000
Operating cash flow: 12881000
Depreciation & amortization: 6487000
Net tangible assets: -8117000
Owner earnings: 3324000
Return on net tangible assets (%): -40.95109030429962
Capex to operating income (%): 126.44793152639086
Buffett classification: The Gruesome
Stock price: 73.2
P/E ratio: 60.23602269403577
Shares outstanding: 9340698
Book value: 295417000
P/B ratio: 2.3144879732716803
Market cap (USD): 683739093.6
Debt to equity: 0.500126939207967
Current ratio: 2.4286928197139215
Quick ratio: 2.0586319218241043
Effective tax rate (%): 37.45687530803352
Interest coverage ratio: 2.7620173364854215
COGS to revenue (%): 67.47131466355503
SG&A to revenue (%): 28.268426682224817
Free cash flow (dilution-adjusted): 6609000
Buyback yield (%): 0.016088007988665925
Retained earnings: 96966000
Inventory turnover: 4.248756218905473
Receivables turnover: 1.3015456170603217
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.779613062800557
FCF margin (%): 8.03310968494749
Revenue growth (%): 7.65204647754632
Rule of 40 score: 15.685156162493811
Financial ratios for TRNS — quarterly report dated 2025-12-31
Total revenue: 83856000
Gross profit: 25253000
Operating income: 88000
Net income: -1101000
Capital expenditures: 2679000
Operating cash flow: 12145000
Depreciation & amortization: 7130000
Net tangible assets: -2704000
Owner earnings: 3350000
Capex to operating income (%): 3044.3181818181815
Buffett classification: The Gruesome
Stock price: 56.73
P/E ratio: 67.13515742303306
Shares outstanding: 9340698
Book value: 296770000
P/B ratio: 1.7855504179667756
Market cap (USD): 529897797.53999996
Debt to equity: 0.45153148903191026
Current ratio: 2.206756240100497
Quick ratio: 1.8541700802883827
Interest coverage ratio: 0.05854956753160346
COGS to revenue (%): 69.88527952680786
SG&A to revenue (%): 30.009778668193093
Free cash flow (dilution-adjusted): 7406000
Buyback yield (%): 0.00245330327099891
Retained earnings: 95842000
Inventory turnover: 4.5389977538533035
Receivables turnover: 1.4025556967953436
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.020170856321615135
FCF margin (%): 8.831806907078802
Revenue growth (%): 1.9253208868144693
Rule of 40 score: 10.757127793893272
Financial ratios for TSAT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.67
Shares outstanding: 15106055
Market cap (USD): 433090596.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSAT — annual report dated 2022-12-31
Total revenue: 558212500
Gross profit: 518503676.4705882
Operating income: 217974999.99999997
Net income: -17473529.411764704
Capital expenditures: 24044852.94117647
Operating cash flow: 176140441.17647058
Depreciation & amortization: 149804411.76470587
Net tangible assets: -2001503676.4705882
Owner earnings: 108286029.41176468
Capex to operating income (%): 11.031014080136012
Buffett classification: The Great
Stock price: 7.5
Shares outstanding: 15106055
Book value: 1353052941.1764703
P/B ratio: 0.08373317041200946
Market cap (USD): 113295412.5
Debt to equity: 2.1107968254796345
Current ratio: 10.433662395855212
Quick ratio: 10.421859319937454
Interest coverage ratio: 1.3368116308014213
COGS to revenue (%): 7.11356759825546
SG&A to revenue (%): 20.04217769692914
Free cash flow (dilution-adjusted): 102463970.58823527
Buyback yield (%): 0
Retained earnings: 261965441.17647058
Inventory turnover: 26.695007414730597
Receivables turnover: 12.725564476926431
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.69937765101502
FCF margin (%): 18.355728434643666
Rule of 40 score: 18.355728434643666
Financial ratios for TSAT — annual report dated 2023-12-31
Total revenue: 533455303.030303
Gross profit: 504277272.7272727
Operating income: 491308333.3333333
Net income: 441871212.1212121
Capital expenditures: 32515151.515151512
Operating cash flow: 128832575.75757575
Depreciation & amortization: 148304545.45454544
Net tangible assets: -1876849242.4242423
Owner earnings: 557660606.060606
Return on net tangible assets (%): -29.712594568346933
Capex to operating income (%): 6.618074498054822
Buffett classification: The Great
Stock price: 10.43
P/E ratio: 0.35656578054417337
Shares outstanding: 15106055
Book value: 1817411363.6363635
P/B ratio: 0.08669262050543919
Market cap (USD): 157556153.65
Debt to equity: 1.3465531018769203
Current ratio: 13.190500047194812
Quick ratio: 13.15915543067082
Effective tax rate (%): 13.315578436122497
Interest coverage ratio: 2.3934683363042843
COGS to revenue (%): 5.469629814772474
SG&A to revenue (%): 16.745744226107384
Free cash flow (dilution-adjusted): 61255303.03030302
Buyback yield (%): 0
Retained earnings: 404589393.93939394
Inventory turnover: 8.921704887653462
Receivables turnover: 7.427937003554891
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.501371436584478
FCF margin (%): 11.48274329308212
Revenue growth (%): -4.435084662148733
Rule of 40 score: 7.047658630933387
Financial ratios for TSAT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.17
Shares outstanding: 15106055
Market cap (USD): 198946744.35
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSAT — annual report dated 2024-12-31
Total revenue: 399331468.5314686
Gross profit: 372777622.37762237
Operating income: 157109090.9090909
Net income: -61342657.34265734
Capital expenditures: 45317482.51748252
Operating cash flow: 43681118.881118886
Depreciation & amortization: 96930769.23076923
Net tangible assets: -1678432167.8321679
Owner earnings: -9729370.62937063
Capex to operating income (%): 28.84459597802961
Buffett classification: The Good
Stock price: 16.44
Shares outstanding: 15106055
Book value: 1745947552.4475527
P/B ratio: 0.14223997957548049
Market cap (USD): 248343544.20000002
Debt to equity: 1.253648308470564
Current ratio: 3.980356850548371
Quick ratio: 3.974678265478724
Interest coverage ratio: 0.9211133751798841
COGS to revenue (%): 6.649575164085429
SG&A to revenue (%): 19.320752866679275
Free cash flow (dilution-adjusted): -13950349.650349652
Buyback yield (%): 0
Retained earnings: 326806293.7062937
Inventory turnover: 26.061770761839398
Receivables turnover: 3.0345142759973007
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3589385882040204
FCF margin (%): -3.4934260757489795
Revenue growth (%): -25.142469057283982
Rule of 40 score: -28.63589513303296
Financial ratios for TSAT — quarterly report dated 2024-12-31
Gross profit: 82534965.03496504
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.44
Shares outstanding: 15106055
Market cap (USD): 248343544.20000002
Buyback yield (%): 0
Inventory turnover: 6.842827728208648
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSAT — quarterly report dated 2025-03-31
Total revenue: 81642657.34265734
Gross profit: 76944755.24475525
Operating income: 21572727.272727273
Net income: -10865734.265734266
Capital expenditures: 24296503.4965035
Operating cash flow: 97149650.34965035
Depreciation & amortization: 25739860.139860142
Net tangible assets: -1672790909.0909092
Owner earnings: -9422377.622377623
Capex to operating income (%): 112.62601705079582
Buffett classification: The Gruesome
Stock price: 18.83
Shares outstanding: 15106055
Book value: 1708721678.3216786
P/B ratio: 0.16646772804415189
Market cap (USD): 284447015.65
Debt to equity: 1.372312840089839
Current ratio: 5.634421087038184
Quick ratio: 5.634421087038184
Interest coverage ratio: 0.5444197373994071
COGS to revenue (%): 5.7542248755877985
SG&A to revenue (%): 22.332525332122763
Free cash flow (dilution-adjusted): 70586713.28671329
Buyback yield (%): 0
Retained earnings: 319365034.96503496
Receivables turnover: 1.2813508352174199
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.44578275124646194
FCF margin (%): 86.45812812101174
Rule of 40 score: 86.45812812101174
Financial ratios for TSAT — quarterly report dated 2025-06-30
Total revenue: 77449635.03649634
Gross profit: 74278832.11678831
Operating income: 13136496.350364963
Net income: 55130656.93430656
Capital expenditures: 25694160.583941605
Operating cash flow: -22385401.459854014
Depreciation & amortization: 27410948.905109487
Net tangible assets: -1674334306.5693429
Owner earnings: 56847445.25547445
Return on net tangible assets (%): -3.395226689940615
Capex to operating income (%): 195.59371006278826
Buffett classification: The Gruesome
Stock price: 24.44
P/E ratio: 8.34050896156028
Shares outstanding: 15106055
Book value: 1663647445.2554746
P/B ratio: 0.2219172008185339
Market cap (USD): 369191984.20000005
Debt to equity: 1.3981985760774516
Current ratio: 5.081380041473474
Quick ratio: 5.081380041473474
Effective tax rate (%): 4.787777175488799
Interest coverage ratio: 0.33390229874394706
COGS to revenue (%): 4.0940191883588115
SG&A to revenue (%): 20.312706161762765
Free cash flow (dilution-adjusted): -49795620.4379562
Buyback yield (%): 0
Retained earnings: 355724087.5912408
Receivables turnover: 1.4867030965391619
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.27340235766807247
FCF margin (%): -64.29419636966807
Revenue growth (%): -5.135822917378506
Rule of 40 score: -69.43001928704658
Financial ratios for TSAT — quarterly report dated 2025-09-30
Total revenue: 72705035.97122303
Gross profit: 69271942.44604316
Operating income: 4119424.460431655
Net income: -25373381.29496403
Capital expenditures: 21822302.158273384
Operating cash flow: -8162589.928057554
Depreciation & amortization: 26965467.62589928
Net tangible assets: -1683263309.352518
Owner earnings: -20230215.827338133
Capex to operating income (%): 529.7415298637793
Buffett classification: The Gruesome
Stock price: 26.5
P/E ratio: 21.18993096345432
Shares outstanding: 15106055
Book value: 1617282733.8129501
P/B ratio: 0.24752039277400625
Market cap (USD): 400310457.5
Debt to equity: 1.4720187471391528
Current ratio: 4.113070158697535
Quick ratio: 4.113070158697535
Interest coverage ratio: 0.10513173597723308
COGS to revenue (%): 4.721947358005146
SG&A to revenue (%): 22.203641401147834
Free cash flow (dilution-adjusted): -32156115.107913673
Buyback yield (%): 0
Retained earnings: 325269784.1726619
Receivables turnover: 1.6429047518410742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.0851873407386513
FCF margin (%): -44.228181278448446
Revenue growth (%): -6.126044445577481
Rule of 40 score: -50.35422572402592
Financial ratios for TSAT — annual report dated 2025-12-31
Total revenue: 305077372.2627737
Gross profit: 288486861.3138686
Operating income: 41818248.17518248
Net income: -113397080.29197079
Capital expenditures: 102573722.62773722
Operating cash flow: 48689051.094890505
Depreciation & amortization: 108681021.8978102
Net tangible assets: -1551848905.109489
Owner earnings: -107289781.02189781
Capex to operating income (%): 245.2845996753417
Buffett classification: The Gruesome
Stock price: 29.1
Shares outstanding: 15106055
Book value: 1291675912.4087596
P/B ratio: 0.340322364361696
Market cap (USD): 439586200.5
Debt to equity: 1.996905508375922
Current ratio: 0.2508138825452941
Quick ratio: 0.2503659457074026
Interest coverage ratio: 0.2619172796554767
COGS to revenue (%): 5.438132243585449
SG&A to revenue (%): 22.16022739235709
Free cash flow (dilution-adjusted): -56910218.978102185
Buyback yield (%): 0
Retained earnings: 241470072.99270073
Inventory turnover: 15.295423956931359
Receivables turnover: 6.492621244601858
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7433013089593896
FCF margin (%): -18.654355960914547
Revenue growth (%): -23.60297239166048
Rule of 40 score: -42.25732835257503
Financial ratios for TSAT — quarterly report dated 2025-12-31
Total revenue: 68643065.69343065
Gross profit: 63610218.978102185
Operating income: 4867883.211678832
Net income: -91637226.27737226
Capital expenditures: 29378102.18978102
Operating cash flow: -22048175.18248175
Depreciation & amortization: 27043795.620437954
Net tangible assets: -1551848905.109489
Owner earnings: -93971532.84671533
Capex to operating income (%): 603.5087719298245
Buffett classification: The Gruesome
Stock price: 29.1
Shares outstanding: 15106055
Book value: 1291675912.4087596
P/B ratio: 0.340322364361696
Market cap (USD): 439586200.5
Debt to equity: 1.996905508375922
Current ratio: 0.2508138825452941
Quick ratio: 0.2503659457074026
Interest coverage ratio: 0.12478482149539706
COGS to revenue (%): 7.331908422921918
SG&A to revenue (%): 23.984219648876557
Free cash flow (dilution-adjusted): -48167153.28467153
Buyback yield (%): 0
Retained earnings: 241470072.99270073
Inventory turnover: 4.639973082099596
Receivables turnover: 1.4608537608351195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.20293024086593306
FCF margin (%): -70.17045756638063
Revenue growth (%): -5.586917362093219
Rule of 40 score: -75.75737492847385
Financial ratios for UMD.DE — annual report dated 2021-12-31
Total revenue: 339561.9318181818
Gross profit: 296056.07954545453
Operating income: -467199.8863636364
Net income: -399472.875
Capital expenditures: 1995454.5454545454
Operating cash flow: -194223.14772727274
Depreciation & amortization: 6112500
Net tangible assets: 55800364.61363636
Owner earnings: 3717572.5795454546
Buffett classification: The Gruesome
Stock price: 101.13636363636364
Shares outstanding: 2454274
Book value: 55800364.61363637
P/B ratio: 4.448292577403951
Market cap (USD): 248216347.72727275
Debt to equity: 7.270235974097535e-07
Current ratio: 25.741395128594345
Quick ratio: 22.41039860295317
Interest coverage ratio: -30.75366453531688
COGS to revenue (%): 12.812346790400063
SG&A to revenue (%): 2.3035093678519614
Free cash flow (dilution-adjusted): -194223.14772727274
Buyback yield (%): 10.750255946533006
Retained earnings: 805636.6022727272
Inventory turnover: 0.017130863444039548
Receivables turnover: 0.17327726295981305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8304910610709926
FCF margin (%): -57.19815136146339
Rule of 40 score: -57.19815136146339
Financial ratios for UMD.DE — annual report dated 2022-12-31
Total revenue: 21276.595744680853
Gross profit: -159588.6489361702
Operating income: -11116737.202127662
Net income: -11041748.44680851
Capital expenditures: 0
Operating cash flow: -601777.2340425532
Depreciation & amortization: 9694680.85106383
Net tangible assets: 41166103.38297872
Owner earnings: -1347067.5957446788
Return on net tangible assets (%): -3.272273752054127
Buffett classification: The Gruesome
Stock price: 18.56382978723404
Shares outstanding: 2454274
Book value: 41166103.38297872
P/B ratio: 1.1067533976527006
Market cap (USD): 45560724.78723404
Debt to equity: 1.0362791462483648e-06
Current ratio: 19.20911459183408
Quick ratio: 19.20911459183408
Interest coverage ratio: -581.3898727641651
COGS to revenue (%): 850.06665
SG&A to revenue (%): 101.37449999999998
Free cash flow (dilution-adjusted): -601777.2340425532
Buyback yield (%): 0
Retained earnings: 723436.244680851
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.999167150009132
FCF margin (%): -2828.353
Revenue growth (%): -93.73410451791358
Rule of 40 score: -2922.0871045179138
Financial ratios for UMD.DE — annual report dated 2023-12-31
Total revenue: 240243.51111111112
Gross profit: 37265.36666666667
Operating income: -35042826.199999996
Net income: -34991563.744444445
Capital expenditures: 0
Depreciation & amortization: 34876124.11111111
Net tangible assets: 7996894.166666666
Owner earnings: -115439.63333333284
Return on net tangible assets (%): -1.4435558471502363
Buffett classification: The Gruesome
Stock price: 6.933333333333334
Shares outstanding: 2454274
Book value: 7996894.166666668
P/B ratio: 2.1278635653654288
Market cap (USD): 17016299.733333334
Debt to equity: 7.526533130796368e-06
Current ratio: 0.8059124148776625
Quick ratio: 0.8059124148776625
Interest coverage ratio: -1303.0006168261752
COGS to revenue (%): 84.48850231404099
Buyback yield (%): 0
Retained earnings: 748327.7888888889
Receivables turnover: 12.77830599026051
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -320.4267020540285
Revenue growth (%): 1029.1445022222222
Rule of 40 score: 1029.1445022222222
Financial ratios for UMD.DE — annual report dated 2024-12-31
Total revenue: 120642.66666666667
Gross profit: 79811.82291666667
Operating income: -811127.3229166666
Net income: -1028802.6145833334
Capital expenditures: 0
Depreciation & amortization: 246.51041666666669
Net tangible assets: 6468285.666666667
Owner earnings: -1028556.1041666667
Return on net tangible assets (%): -15.901525646388428
Buffett classification: The Gruesome
Stock price: 3.125
Shares outstanding: 2454274
Book value: 6468285.666666667
P/B ratio: 1.1857247260312198
Market cap (USD): 7669606.25
Debt to equity: 5.116309282773895e-06
Current ratio: 0.07176242522809935
Quick ratio: 0.07176242522809935
Interest coverage ratio: -2.613799740910041
COGS to revenue (%): 33.84444730719922
Buyback yield (%): 0
Retained earnings: 701557.3020833334
Receivables turnover: 6.844650371140845
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.697718765173743
Revenue growth (%): -49.783173702090046
Rule of 40 score: -49.783173702090046
Financial ratios for UMD.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 6468285.666666667
Buffett classification: The Gruesome
Stock price: 3.125
Shares outstanding: 2454274
Book value: 6468285.666666667
P/B ratio: 1.1857247260312198
Market cap (USD): 7669606.25
Debt to equity: 5.116309282773895e-06
Current ratio: 0.07176242522809935
Quick ratio: 0.07176242522809935
Buyback yield (%): 0
Retained earnings: 701557.3020833334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UMD.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 6988600.8
Buffett classification: The Gruesome
Stock price: 4
Shares outstanding: 2454274
Book value: 6988600.800000001
P/B ratio: 1.4047298280365361
Market cap (USD): 9817096
Debt to equity: 0
Current ratio: 0.023247277760814335
Quick ratio: 0.023247277760814335
Buyback yield (%): 0
Retained earnings: 475589.9411764706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UTG — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.91
Shares outstanding: 91428150
Market cap (USD): 2277475216.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UTG — annual report dated 2022-10-31
Total revenue: -214484719
Net income: -222018993
Capital expenditures: 0
Operating cash flow: -111419849
Net tangible assets: 1994717344
Owner earnings: -222018993
Return on net tangible assets (%): -11.130348551278251
Buffett classification: The Gruesome
Stock price: 21.61
Shares outstanding: 91428150
Book value: 1994717344
P/B ratio: 0.9904973892381215
Market cap (USD): 1975762321.5
Debt to equity: 0.25066208077248264
Free cash flow (dilution-adjusted): -111419849
Buyback yield (%): 0
Retained earnings: 93182599
Receivables turnover: -38.87957205133629
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UTG — annual report dated 2023-10-31
Total revenue: -69887757
Net income: -74371377
Capital expenditures: 0
Operating cash flow: 4836126
Net tangible assets: 1893768598
Owner earnings: -74371377
Return on net tangible assets (%): -3.9271628581519016
Buffett classification: The Gruesome
Stock price: 20.72
Shares outstanding: 91428150
Book value: 1893768598
P/B ratio: 1.0003287994112149
Market cap (USD): 1894391268
Debt to equity: 0.27458476212414207
Free cash flow (dilution-adjusted): 4836126
Buyback yield (%): 0
Retained earnings: -151397069
Receivables turnover: -15.005761160477048
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UTG — annual report dated 2024-10-31
Total revenue: 870207251
Net income: 865292139
Capital expenditures: 0
Operating cash flow: -233118701
Net tangible assets: 2860740800
Owner earnings: 865292139
Return on net tangible assets (%): 30.247135252519207
Buffett classification: The Gruesome
Stock price: 29.56
P/E ratio: 3.1233568319751024
Shares outstanding: 91428150
Book value: 2860740800
P/B ratio: 0.9447259653863083
Market cap (USD): 2702616114
Debt to equity: 0.2272138741126075
COGS to revenue (%): 0
SG&A to revenue (%): 0.5648208509354284
Free cash flow (dilution-adjusted): -233118701
Buyback yield (%): 0
Retained earnings: 526698316
Receivables turnover: 157.30308103228427
Capitalized R&D asset: 0
FCF margin (%): -26.788871355888073
Rule of 40 score: -26.788871355888073
Financial ratios for UTG — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 2860740800
Buffett classification: The Gruesome
Stock price: 29.56
Shares outstanding: 91428150
Book value: 2860740800
P/B ratio: 0.9447259653863083
Market cap (USD): 2702616114
Debt to equity: 0.2272138741126075
Buyback yield (%): 0
Retained earnings: 526698316
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UTG — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 2906074967
Buffett classification: The Gruesome
Stock price: 30.67
Shares outstanding: 91428150
Market cap (USD): 2804101360.5
Buyback yield (%): 0
Retained earnings: 525914608
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VISHNU.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.202162732427799
Shares outstanding: 67315284
Market cap (USD): 282869777.7475933
Buyback yield (%): 0
Retained earnings: 31346024.00105499
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VISHNU.NS — annual report dated 2023-03-31
Total revenue: 169020194.88428748
Gross profit: 60075383.67844093
Operating income: 25026406.82095006
Net income: 16633836.784409259
Capital expenditures: 14027990.25578563
Operating cash flow: 16352314.250913521
Depreciation & amortization: 3223288.6723507917
Net tangible assets: 50470645.5542022
Owner earnings: 5829135.20097442
Return on net tangible assets (%): 11.549555463312446
Capex to operating income (%): 56.052754021574295
Buffett classification: The Good
Stock price: 3.2816077953714986
P/E ratio: 13.280301086583707
Shares outstanding: 67315284
Book value: 50471912.30207065
P/B ratio: 4.376738479809564
Market cap (USD): 220902360.72204632
Debt to equity: 0.7306402132950298
Current ratio: 1.2760298092419986
Quick ratio: 0.7107203064424087
Effective tax rate (%): 26.36037547829913
Interest coverage ratio: 9.12581446064606
COGS to revenue (%): 64.45668299011902
SG&A to revenue (%): 9.891963122267063
Free cash flow (dilution-adjusted): 2056601.7052375153
Buyback yield (%): 0
Retained earnings: 45294933.00852619
Inventory turnover: 4.311819315999352
Receivables turnover: 7.669742325591678
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 30.039603126611876
FCF margin (%): 1.216778685319515
Rule of 40 score: 1.216778685319515
Financial ratios for VISHNU.NS — annual report dated 2024-03-31
Total revenue: 145014953.83139464
Gross profit: 53868401.48698885
Operating income: 20240292.6010313
Net income: 12123767.837870248
Capital expenditures: 14431646.480393333
Operating cash flow: 8094303.873366111
Depreciation & amortization: 4023000.359755366
Net tangible assets: 83718695.2872047
Owner earnings: 1715121.7172322813
Return on net tangible assets (%): 2.0486722963710773
Capex to operating income (%): 71.30157041137835
Buffett classification: The Good
Stock price: 3.8238963531669863
P/E ratio: 21.231573586880724
Shares outstanding: 67315284
Book value: 84082707.75872408
P/B ratio: 3.061350851576168
Market cap (USD): 257406668.99999997
Debt to equity: 0.34062690174376753
Current ratio: 1.5753354202698944
Quick ratio: 0.8132594129150418
Effective tax rate (%): 29.665923904309576
Interest coverage ratio: 6.119856271097945
COGS to revenue (%): 62.85320922860112
SG&A to revenue (%): 8.611829008623895
Free cash flow (dilution-adjusted): -6337342.6070272215
Buyback yield (%): 0
Retained earnings: 56403693.48842787
Inventory turnover: 2.3981636202320447
Receivables turnover: 5.261880985419388
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.55700389085807
FCF margin (%): -4.370130417305443
Revenue growth (%): -14.202587489221042
Rule of 40 score: -18.572717906526485
Financial ratios for VISHNU.NS — annual report dated 2025-03-31
Total revenue: 168506534.95440727
Gross profit: 62864765.02221183
Operating income: 22236953.472059853
Net income: 14805085.340191722
Capital expenditures: 10270166.004208557
Operating cash flow: 10548012.625672199
Depreciation & amortization: 4460731.821370119
Net tangible assets: 108185725.9761515
Owner earnings: 8995651.157353282
Return on net tangible assets (%): 8.31500743391627
Capex to operating income (%): 46.18513060753916
Buffett classification: The Good
Stock price: 5.322791457579648
P/E ratio: 24.201496337683928
Shares outstanding: 67315284
Book value: 108342974.04722935
P/B ratio: 3.307138481204641
Market cap (USD): 358305218.6397479
Debt to equity: 0.36933268361866617
Current ratio: 1.7026303493467978
Quick ratio: 0.8834489056250061
Effective tax rate (%): 24.721575629902443
Interest coverage ratio: 5.100046384800801
COGS to revenue (%): 62.6929809937513
SG&A to revenue (%): 11.429786314726696
Free cash flow (dilution-adjusted): 277846.62146364275
Buyback yield (%): 0
Retained earnings: 69561292.96235679
Inventory turnover: 2.2419890656911994
Receivables turnover: 4.902519309513759
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.65860075211807
FCF margin (%): 0.16488774250732743
Revenue growth (%): 16.19941978557999
Rule of 40 score: 16.36430752808732
Financial ratios for VISHNU.NS — quarterly report dated 2025-03-31
Total revenue: 45721253.21487023
Gross profit: 17231610.94224924
Operating income: 6538274.49146598
Net income: 4552115.969137246
Capital expenditures: 0
Depreciation & amortization: 950607.9027355623
Net tangible assets: 108185725.9761515
Owner earnings: 5502723.871872808
Return on net tangible assets (%): 5.086367746042423
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.322791457579648
P/E ratio: 19.67794873137079
Shares outstanding: 67315284
Book value: 108342974.04722935
P/B ratio: 3.307138481204641
Market cap (USD): 358305218.6397479
Debt to equity: 0.36933268361866617
Current ratio: 1.7026303493467978
Quick ratio: 0.8834489056250061
Effective tax rate (%): 26.90816123497854
Interest coverage ratio: 6.698653763234801
COGS to revenue (%): 62.31159530718007
SG&A to revenue (%): 10.902005524935337
Buyback yield (%): 0
Retained earnings: 69561292.96235679
Inventory turnover: 0.6046232139206513
Receivables turnover: 1.3302114769716042
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.8980857246449165
Rule of 40 score: 0
Financial ratios for VISHNU.NS — quarterly report dated 2025-06-30
Total revenue: 40480505.49964896
Gross profit: 15884776.503627429
Operating income: 5340229.347062954
Net income: 3770711.4439503863
Capital expenditures: 0
Depreciation & amortization: 1179358.7643341916
Owner earnings: 4950070.208284577
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.23929323660192
P/E ratio: 27.84619046194666
Shares outstanding: 67315284
Market cap (USD): 419999796.18113744
Effective tax rate (%): 22.978098909845333
Interest coverage ratio: 5.412557223843071
COGS to revenue (%): 60.75944134698324
SG&A to revenue (%): 11.362800711324066
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -11.462388597687841
Rule of 40 score: -11.462388597687841
Financial ratios for VISHNU.NS — quarterly report dated 2025-09-30
Total revenue: 45076741.82638106
Gross profit: 16307790.304396844
Operating income: 5407249.154453213
Net income: 3707249.154453213
Capital expenditures: 0
Depreciation & amortization: 1154746.3359639233
Net tangible assets: 110739436.30214205
Owner earnings: 4861995.490417136
Return on net tangible assets (%): 4.390482426830892
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.1037204058624575
P/E ratio: 23.168013145578456
Shares outstanding: 67315284
Book value: 112779425.02818489
P/B ratio: 3.0462860445632467
Market cap (USD): 343558388.5772266
Debt to equity: 0.41813279005871423
Current ratio: 1.8461026726248067
Quick ratio: 0.9877818818375381
Effective tax rate (%): 28.182487283591733
Interest coverage ratio: 4.155566337714548
COGS to revenue (%): 63.82216273037563
SG&A to revenue (%): 11.574248800804941
Buyback yield (%): 0
Inventory turnover: 0.5691568054760973
Receivables turnover: 1.4527670762418878
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.67574325812037
Revenue growth (%): 11.354196964689478
Rule of 40 score: 11.354196964689478
Financial ratios for VISHNU.NS — quarterly report dated 2025-12-31
Total revenue: 45604065.946307234
Gross profit: 16717088.114069289
Operating income: 5671482.677954773
Net income: 3760799.8217667374
Capital expenditures: 0
Depreciation & amortization: 1206483.2349337195
Owner earnings: 4967283.056700457
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.020942408376964
P/E ratio: 25.666811529344855
Shares outstanding: 67315284
Market cap (USD): 405301448.1675393
Effective tax rate (%): 22.51868715962059
Interest coverage ratio: 3.764577572056018
COGS to revenue (%): 63.34298758853771
SG&A to revenue (%): 10.75533046058785
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.1698363691795528
Rule of 40 score: 1.1698363691795528
Financial ratios for VUZI — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1870459
Buffett classification: The Gruesome
Stock price: 8.67
Shares outstanding: 83158258
Market cap (USD): 720982096.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VUZI — annual report dated 2022-12-31
Total revenue: 11835882
Gross profit: 1483126
Operating income: -42312243
Net income: -40763573
Capital expenditures: 1723622
Operating cash flow: -24521082
Depreciation & amortization: 2587901
Net tangible assets: 80334243
Owner earnings: -39899294
Return on net tangible assets (%): -49.66660854699284
Buffett classification: The Gruesome
Stock price: 3.64
Shares outstanding: 83158258
Book value: 115489739
P/B ratio: 2.6209779478330972
Market cap (USD): 302696059.12
Debt to equity: 0.008279220372989154
Current ratio: 5.932444929286857
Quick ratio: 5.194884874727685
COGS to revenue (%): 87.46923972374852
R&D to revenue (%): 107.10387278278036
SG&A to revenue (%): 246.00701493982453
Free cash flow (dilution-adjusted): -59167451
Buyback yield (%): 0.6626264001689062
Retained earnings: -243835716
Inventory turnover: 0.918777465575207
Receivables turnover: 2.7558601612878815
Capitalized R&D asset: 12676688
ROCI (R&D-adjusted, %): -26.35689341027621
FCF margin (%): -499.8989597902378
Rule of 40 score: -499.8989597902378
Financial ratios for VUZI — annual report dated 2023-12-31
Total revenue: 12129139
Gross profit: -2634730
Operating income: -50353650
Net income: -50149077
Capital expenditures: 5323483
Operating cash flow: -26277824
Depreciation & amortization: 4931692
Net tangible assets: 50954727
Owner earnings: -50540868
Return on net tangible assets (%): -99.18779076178743
Buffett classification: The Gruesome
Stock price: 2.09
Shares outstanding: 83158258
Book value: 80793857
P/B ratio: 2.1511630422595123
Market cap (USD): 173800759.22
Debt to equity: 0.0037278205445743233
Current ratio: 7.956135289002314
Quick ratio: 6.1347897837332965
COGS to revenue (%): 121.72231681078105
R&D to revenue (%): 101.73462436204252
SG&A to revenue (%): 258.08909437017746
Free cash flow (dilution-adjusted): -55569874
Buyback yield (%): 0.2708601516545205
Retained earnings: -293984793
Inventory turnover: 1.554023587390656
Receivables turnover: 2.8867025661822945
Capitalized R&D asset: 20832914.96
ROCI (R&D-adjusted, %): -45.54916713826523
Rosenberg metric: -0.3248368974609141
FCF margin (%): -458.15184408390405
Revenue growth (%): 2.4776945224698927
Rule of 40 score: -455.67414956143415
Financial ratios for VUZI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.17
Shares outstanding: 83158258
Market cap (USD): 97295161.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VUZI — annual report dated 2024-12-31
Total revenue: 5754556
Gross profit: -5599670
Operating income: -43583150
Net income: -73538157
Capital expenditures: 1358991
Operating cash flow: -23739372
Depreciation & amortization: 3930169
Net tangible assets: 33338737
Owner earnings: -70966979
Return on net tangible assets (%): -212.8664292231586
Buffett classification: The Gruesome
Stock price: 3.94
Shares outstanding: 83158258
Book value: 37292985
P/B ratio: 8.785661338720942
Market cap (USD): 327643536.52
Debt to equity: 0.013252787353975554
Current ratio: 12.651058835671336
Quick ratio: 8.572259835731462
COGS to revenue (%): 197.30846306821934
R&D to revenue (%): 167.2840094005515
SG&A to revenue (%): 441.76683657262174
Free cash flow (dilution-adjusted): -38224695
Buyback yield (%): 0
Retained earnings: -367522950
Inventory turnover: 1.3178779221771086
Receivables turnover: 2.5203730177083554
Capitalized R&D asset: 22077246.82
ROCI (R&D-adjusted, %): -76.64490200739121
Rosenberg metric: -0.2402797382786092
FCF margin (%): -664.2509865226788
Revenue growth (%): -52.55593987339084
Rule of 40 score: -716.8069263960696
Financial ratios for VUZI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.94
Shares outstanding: 83158258
Market cap (USD): 327643536.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VUZI — quarterly report dated 2025-03-31
Total revenue: 1580941
Gross profit: -265118
Operating income: -8792819
Net income: -8637626
Capital expenditures: 613397
Operating cash flow: -3453623
Depreciation & amortization: 632148
Net tangible assets: 28927778
Owner earnings: -8618875
Return on net tangible assets (%): -29.794459152721654
Buffett classification: The Gruesome
Stock price: 2.04
Shares outstanding: 83158258
Book value: 32846633
P/B ratio: 5.164695155208146
Market cap (USD): 169642846.32
Debt to equity: 0.010943069872641133
Current ratio: 7.678006383113732
Quick ratio: 5.3284995223811995
COGS to revenue (%): 116.76963276934433
R&D to revenue (%): 164.82841548166567
SG&A to revenue (%): 347.7960278087544
Free cash flow (dilution-adjusted): -7096756
Buyback yield (%): 0
Retained earnings: -376160576
Inventory turnover: 0.2694977035763071
Receivables turnover: 0.9071265164525382
Capitalized R&D asset: 2605840
ROCI (R&D-adjusted, %): -19.901551954734817
FCF margin (%): -448.8944242701025
Rule of 40 score: -448.8944242701025
Financial ratios for VUZI — quarterly report dated 2025-06-30
Total revenue: 1295709
Gross profit: -761370
Operating income: -7814532
Net income: -7666254
Capital expenditures: 727476
Operating cash flow: -4788189
Depreciation & amortization: 777062
Net tangible assets: 29947683
Owner earnings: -7616668
Return on net tangible assets (%): -25.433246371680905
Buffett classification: The Gruesome
Stock price: 2.92
Shares outstanding: 83158258
Book value: 33864476
P/B ratio: 7.170408110256895
Market cap (USD): 242822113.35999998
Debt to equity: 0.0066337952490391405
Current ratio: 7.676629769293767
Quick ratio: 5.541753786073359
COGS to revenue (%): 158.7608791788897
R&D to revenue (%): 198.41438162426903
SG&A to revenue (%): 317.1682839279499
Free cash flow (dilution-adjusted): -6452752
Buyback yield (%): 0
Retained earnings: -383826831
Inventory turnover: 0.3171713717343165
Receivables turnover: 0.81043405488171
Capitalized R&D asset: 4316785.8
ROCI (R&D-adjusted, %): -18.253011219236345
Rosenberg metric: -0.19043839990175912
FCF margin (%): -498.0093524086041
Revenue growth (%): -18.041913012566564
Rule of 40 score: -516.0512654211707